Testing heart scans to better detect pulmonary hypertension in patients
Studies heart tracings and ultrasound scans to help spot pulmonary hypertension in adults.
Plain-language title generated from the registry record
Registry title: Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography
Key facts
- Where
- Bath, Cambridge, Glasgow, London, and Sheffield, United KingdomSee the 5 sites
Where in United Kingdom
- Royal United Hospital NHS Foundation TrustBath, United KingdomTaking people
- Royal Papworth HospitalCambridge, United KingdomNot yet recruiting
- Golden Jubilee HospitalGlasgow, United KingdomNot yet recruiting
- Royal Free NHS Foundation TrustLondon, United KingdomNot yet recruiting
- Sheffield Teaching Hospitals NHS Foundation TrustSheffield, United KingdomNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Royal United Hospitals Bath NHS Foundation Trust
- Trial code
- NCT06386185
- Record updated
- 18 June 2025
- Original description
The goal of this observational study is to assess the efficacy that the addition of novel markers cardiac function, particularly of right ventricular (RV) function in echocardiography, and ECG have in detecting pulmonary hypertension.Read full original descriptionShow less
Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography
The goal of this observational study is to assess the efficacy that the addition of novel markers cardiac function, particularly of right ventricular (RV) function in echocardiography, and ECG have in detecting pulmonary hypertension.
The main questions it aims to answer are:
Can novel markers in ECG and echocardiography suggest the presence of PH? Can existing screening guidelines be improved with the addition of these markers?
Inclusion: Patients 18+ who have undergone TTE, ECG and RHC as part of their clinical care.
Exclusion: Known or suspected congenital heart disease; Patients <18 years old; Patient has opted-out of allowing their data to be used for research and planning (via the national data opt-out choice in England, or equivalent data protection scheme in Scotland).